387 related articles for article (PubMed ID: 23132513)
21. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmanova H; Urbanek K; Grundmann M; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):342-7. PubMed ID: 22660225
[TBL] [Abstract][Full Text] [Related]
22. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
Joy MS; Matzke GR; Frye RF; Palevsky PM
Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
[TBL] [Abstract][Full Text] [Related]
23. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
[TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
26. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758
[TBL] [Abstract][Full Text] [Related]
27. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
28. Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.
Villa G; Cassetta MI; Tofani L; Valente S; Chelazzi C; Falsini S; De Gaudio AR; Novelli A; Ronco C; Adembri C
Int J Antimicrob Agents; 2015 Oct; 46(4):465-8. PubMed ID: 26315198
[TBL] [Abstract][Full Text] [Related]
29. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
[TBL] [Abstract][Full Text] [Related]
30. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
Dai X; Li T; Zeng Z; Fu C; Wang S; Cai Y; Chen Z
BMC Nephrol; 2016 Oct; 17(1):154. PubMed ID: 27760529
[TBL] [Abstract][Full Text] [Related]
31. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.
Lopez ND; Phillips KM
Pharmacotherapy; 2014 Sep; 34(9):e162-8. PubMed ID: 25074285
[TBL] [Abstract][Full Text] [Related]
32. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
[TBL] [Abstract][Full Text] [Related]
33. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Fish DN; Teitelbaum I; Abraham E
Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
[TBL] [Abstract][Full Text] [Related]
35. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
[TBL] [Abstract][Full Text] [Related]
37. Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations.
Frazee EN; Kuper PJ; Schramm GE; Larson SL; Kashani KB; Osmon DR; Leung N
Antimicrob Agents Chemother; 2012 Dec; 56(12):6181-5. PubMed ID: 22985887
[TBL] [Abstract][Full Text] [Related]
38. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Jamal JA; Udy AA; Lipman J; Roberts JA
Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
Rider TR; Silinskie KM; Hite MS; Bress J
Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
